IP Verse

Pohlman competitive analysis

Explore the latest publications and patents granted to Pohlman, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Pohlman against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 2, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3630946	Cell Culture Methods	UCB BIOPHARMA	Dec 23, 2024
EP3530670	Recombinant Proteins Derived From Genus Limulus, And Dna Molecules Encoding Same	SEIKAGAKU	Nov 22, 2024
EP4219687	Methods For Isolating, Culturing, And Genetically Engineering Immune Cell Populations For Adoptive Therapy	JUNO THERAPEUTICS	Oct 29, 2024
EP3384049	Methods Of Associating Genetic Variants With A Clinical Outcome In Patients Suffering From Age-Related Macular Degeneration Treated With Anti-Vegf	REGENERON PHARMACEUTICALS	Apr 30, 2024
EP3597749	Methods And Compositions For Rna-Directed Target Dna Modification And For Rna-Directed Modulation Of Transcription	CHARPENTIER	Apr 26, 2024
EP3911354	Aav-Mediated Gene Therapy Restoring The Otoferlin Gene	CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS	Apr 19, 2024
EP3600806	Transparent Wood And A Method For Its Preparation	CELLUTECH	Mar 7, 2024
EP3733847	Composition For Cleaving A Target Dna Comprising A Guide Rna Specific For The Target Dna And Cas Protein-Encoding Nucleic Acid Or Cas Protein, And Use Thereof	TOOLGEN INCORPORATED	Mar 1, 2023
EP3464373	Use Of Anti-Pd-1 Antibody In The Treatment Of Patients With Colorectal Cancer	BRISTOL MYERS SQUIBB	Jul 26, 2022
EP3498734	Combination Of A Pd-1 Antagonist And A Vegfr Inhibitor For Treating Cancer	MERCK SHARP & DOHME	May 31, 2022

Discover the latest PTAB cases involving Pohlman, highlighting their recent legal challenges and patent disputes.

IP litigation analysis comparing Pohlman with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 2, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced	Strategy Type
POHLMAN	30	-	-	-	Highly Aggressive
CHARPENTIER	-	18	-	-	Non-Active
F HOFFMANN LA ROCHE	16	140	-	-	Defensive
GENENTECH	-	86	-	65	Non-Active